Relationship of the transforming growth factor-β1 T29→C polymorphism to breast cancer risk in women with, and without, proliferative breast disease.

被引：0
|
作者：
Sanders, ME [1 ]
Parl, FF [1 ]
Page, DL [1 ]
Roodi, N [1 ]
Schuyler, PA [1 ]
Plummer, WD [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S162 / S162
页数：1
相关论文
共 50 条
  • [31] Transforming growth factor-β1 is the predominant isoform required for breast cancer cell outgrowth in bone
    A A Mourskaia
    Z Dong
    S Ng
    M Banville
    J C Zwaagstra
    M D O'Connor-McCourt
    P M Siegel
    Oncogene, 2009, 28 : 1005 - 1015
  • [32] Transforming growth factor-\#946;1 mediated invasion of inflammatory breast cancer stem cells
    Hall, Carolyn
    Woodward, Wendy
    Lucci, Anthony
    Cristofanilli, Massimo
    Robertson, Fredika
    CANCER RESEARCH, 2009, 69
  • [33] Detection of transforming growth factor-β1 in human plasma -: A pilot study on breast cancer patients
    Ivanovic, V
    Todorovic-Rakovic, N
    Demajo, M
    Neskovic-Konstantinovic, Z
    Nikolic-Vukosavljevic, D
    Ivanisevic-Milovanovic, O
    Mitrovic, L
    JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 2001, 20 (02): : 81 - 87
  • [34] Transforming growth factor-β1 is the predominant isoform required for breast cancer cell outgrowth in bone
    Mourskaia, A. A.
    Dong, Z.
    Ng, S.
    Banville, M.
    Zwaagstra, J. C.
    O'Connor-McCourt, M. D.
    Siegel, P. M.
    ONCOGENE, 2009, 28 (07) : 1005 - 1015
  • [35] The-509C/T polymorphism of transforming growth factor-β1 is associated with increased risk for development of chronic idiopathic neutropenia
    Eliopoulos, Dimitrios G.
    Mavroudi, Irene
    Pontikoglou, Charalampos
    Ximeri, Maria
    Stavroulaki, Emily
    Pyrovolaki, Katerina
    Velegraki, Maria
    Spanoudakis, Michael
    Goulielmos, George
    Papadaki, Helen A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (06) : 535 - 540
  • [36] The+869T/C polymorphism in the transforming growth factor-β1 gene is associated with the severity and intractability of autoimmune thyroid disease
    Yamada, H.
    Watanabe, M.
    Nanba, T.
    Akamizu, T.
    Iwatani, Y.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 151 (03): : 379 - 382
  • [37] Transforming growth factor-β1 29T>C genetic polymorphism is associated with lymph node metastasis in patients with adenocarcinoma of the lung
    Minamiya, Yoshihiro
    Miura, Masatomo
    Hinai, Yudai
    Saito, Hajime
    Ito, Manabu
    Ono, Takashi
    Toda, Hiroshi
    Motoyama, Satoru
    Ogawa, Jun-ichi
    TUMOR BIOLOGY, 2010, 31 (05) : 437 - 441
  • [38] Increased abdominal obesity, insulin and glucose levels in nondiabetic subjects with a T29C polymorphism of the transforming growth factor-β1 gene
    Rosmond, R
    Chagnon, M
    Bouchard, C
    Björntorp, P
    HORMONE RESEARCH, 2003, 59 (04) : 191 - 194
  • [39] Role of transforming growth factor-β1-509 C/T promoter polymorphism in gastric cancer in south Indian population
    Bhayal, Amar Chand
    Prabhakar, B.
    Rao, K. Pandu Ranga
    Penchikala, Anitha
    Ayesha, Qamar
    Jyothy, A.
    Nallari, Pratibha
    Venkateshwari, A.
    TUMOR BIOLOGY, 2011, 32 (05) : 1049 - 1053
  • [40] Transforming growth factor beta1 (TGFβ1) polymorphisms and breast cancer risk
    Amani, Davar
    Khalilnezhad, Ahad
    Ghaderi, Abbas
    Niikawa, Norrio
    Yoshiura, Ko-ichiro
    TUMOR BIOLOGY, 2014, 35 (05) : 4757 - 4764
12345